Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03551951Recruiting

Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Role: collaborator

NCT03806491Not ApplicableCompleted

CBT-I on Alcohol Treatment Outcomes Among Veterans

Role: collaborator

NCT05744115Phase 3Terminated

Ga-68-PSMA-11 in Men With Prostate Cancer

Role: collaborator

NCT04285606Not ApplicableWithdrawn

Effect of Postop Rehab Methods on Outcomes Following Reverse Shoulder Arthroplasty

Role: collaborator

NCT02891421Not ApplicableCompleted

Therapeutic Horsemanship in Veterans

Role: collaborator

All 5 trials loaded